Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Obstructive sleep apnoea (OSA) is associated with higher cancer incidence, tumour aggressiveness and cancer mortality, as well as greater severity of infections, which have been attributed to an immune deregulation. We studied the expression of programmed cell death (PD)-1 receptor and its ligand (PD-L1) on immune cells from patients with OSA, and its consequences on immune-suppressing activity. We report that PD-L1 was overexpressed on monocytes and PD-1 was overexpressed on CD8+T-cells in a severity-dependent manner. PD-L1 and PD-1 overexpression were induced in both the human in vitro and murine models of intermittent hypoxia, as well as by hypoxia-inducible factor-1α transfection. PD-L1/PD-1 crosstalk suppressed T-cell proliferation and activation of autologous T-lymphocytes and impaired the cytotoxic activity of CD8+T-cells. In addition, monocytes from patients with OSA exhibited high levels of retinoic acid related orphan receptor, which might explain the differentiation of myeloid-derived suppressor cells. Intermittent hypoxia upregulated the PD-L1/PD-1 crosstalk in patients with OSA, resulting in a reduction in CD8+T-cell activation and cytotoxicity, providing biological plausibility to the increased incidence and aggressiveness of cancer and the higher risk of infections described in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“reduces immunosurveillance,888”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [888]
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
Heinzer, R., Vat, S., Marques-Vidal, P., Marti-Soler, H., Andries, D., Tobback, N., Mooser, V, Preisig, M., Malhotra, A., Waeber, G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00043-0 · Cited by 2,481
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E., & Rosenberg, S. A. (2009) · Blood · doi:10.1182/blood-2008-12-195792 · Cited by 1,766
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,339
Cited by
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Vito, A., El-Sayes, N., & Mossman, K. (2020) · Cells · doi:10.3390/cells9040992 · Cited by 270
Wu, Q., Zhou, W., Yin, S., Zhou, Y., Chen, T., Qian, J., Su, R., Hong, L., Lu, H., Zhang, F., et al. (2019) · Hepatology · doi:10.1002/hep.30593 · Cited by 269
“Given that PD-L1, a member of the B7 family, can respond to hypoxia,(26,27) the”
BackgroundHypoxia as a driver of resistance to immunotherapy
Kopecka, J., Salaroglio, I. C., Perez-Ruiz, E., Sarmento-Ribeiro, A. B., Saponara, S., De Las Rivas, J., & Riganti, C. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100787 · Cited by 246
Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 216
Lin, W., Wu, S., Chen, X., Ye, Y., Weng, Y., Pan, Y., Chen, Z., Chen, L., Qiu, X., & Qiu, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00796 · Cited by 181
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
Shen, X., Zhang, L., Li, J., Li, Y., Wang, Y., & Xu, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01337 · Cited by 139
“Hypoxia markedly induces the expression of PD-L1 on the surface of myeloid-derived suppressor cells (MDSCs), macrophages, DCs, monocytes, and tumor cells (201, 203, 204).”
BackgroundPneumonia prevention in the elderly patients: the other sides
Chebib, N., Cuvelier, C., Malézieux-Picard, A., Parent, T., Roux, X., Fassier, T., Müller, F., & Prendki, V. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01437-7 · Cited by 132
Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs
Bailly, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117403 · Cited by 110
Bouglé, A., Tuffet, S., Federici, L., Léone, M., Monsel, A., Dessalle, T., Amour, J., Dahyot‐Fizelier, C., Barbier, F., Luyt, C. E., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06690-5 · Cited by 112
Obesity, sleep apnea, and cancer
Almendros, I., Martínez‐García, M. Á., Farré, R., & Gozal, D. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0549-z · Cited by 96
“Specifically, PD-L1 and PD-1 were overexpressed in monocytes and CD8+ T cells, respectively, in an OSA severitydependent manner [81].”
BackgroundInfluentialSelf-citationShima, T., Shimoda, M., Shigenobu, T., Ohtsuka, T., Nishimura, T., Emoto, K., Hayashi, Y., Iwasaki, T., Abe, T., Asamura, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14272 · Cited by 63
“Age at surgery, year 69 [33-84] 66 [34-79] .”
Cancer and Sleep Apnea: Cutaneous Melanoma as a Case Study
Martínez‐García, M. Á., Campos‐Rodríguez, F., Almendros, I., Rio, F. G., Sánchez‐de‐la‐Torre, M., Farré, R., & Gozal, D. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0577pp · Cited by 58
Self-citationPolasky, C., Steffen, A., Loyal, K., Lange, C. M., Bruchhage, K., & Pries, R. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001047 · Cited by 57
“Intermittent hypoxia has been linked to an upregulation of HIF-1a, which induces an increase of PD-L1 on monocytes (30) and T cells (29).”
BackgroundSleep Apnoea Adverse Effects on Cancer: True, False, or Too Many Confounders?
Gozal, D., Almendros, I., Phipps, A. I., Campos‐Rodríguez, F., Martínez‐García, M. Á., & Farré, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228779 · Cited by 54
“Among these alterations, some include (i) IH-induced HIF activation can up-regulate the co-inhibitory axis of the programmed cell death receptor 1 and its ligand (PD-1/PDL1), thereby conferring a lower proliferative and cytotoxicity capacity to T cells [32,50]; (ii) IH and SF chronic exposure reduce tumour CD8+ T cyto…”
BackgroundSelf-citationCOVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia
Póvoa, H. C. C., Chianca, G. C., & Iorio, N. L. P. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00306-5 · Cited by 56
Wu, G., Lee, Y. Y., Gulla, E. M., Potter, A., Kitzmiller, J. A., Ruben, M. D., Salomonis, N., Whitsett, J. A., Francey, L. J., Hogenesch, J. B., et al. (2021) · eLife · doi:10.7554/elife.63003 · Cited by 52
“Pathways involved in immune responses and regulation can also be activated or suppressed in the presence of IH (Cubillos-Zapata et al., 2017; Lam and Ip, 2019), contributing to comorbid disease initiation and progression.”
BackgroundDifferential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation
Cubillos‐Zapata, C., Almendros, I., Díaz‐García, E., Toledano, V., Casitas, R., Galera, R., López‐Collazo, E., Farré, R., Gozal, D., & Rio, F. G. (2019) · SLEEP · doi:10.1093/sleep/zsz285 · Cited by 53
Self-citationCellular Immune Dysfunction in Obstructive Sleep Apnea
Ludwig, K., Huppertz, T., Radsak, M. P., & Gouveris, H. T. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.890377 · Cited by 52
Cubillos‐Zapata, C., Martínez‐García, M. Á., Campos‐Rodríguez, F., Sánchez‐de‐la‐Torre, M., Nagore, E., Martorell, A., Blasco, L., Vives, E. C., Abad, J., Montserrat, J. M., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01298-2018 · Cited by 49
Self-citationAge‐dependent hypoxia‐induced PD‐L1 upregulation in patients with obstructive sleep apnoea
Cubillos‐Zapata, C., Balbás‐García, C., Ortiz, J. A., Toledano, V., Torres, M., Almendros, I., Casitas, R., Zamarrón, E., García‐Sánchez, A., Feliú, J., et al. (2019) · Respirology · doi:10.1111/resp.13470 · Cited by 41
Self-citationObstructive sleep apnea severity and subsequent risk for cancer incidence
Sillah, A., Watson, N. F., Gozal, D., & Phipps, A. I. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.100886 · Cited by 40
“, 2012a) and a marker of adverse cancer prognosis (Akbarpour et al., 2017; Khalyfa et al., 2016; Santamaria-Martos et al., 2018; Cubillos-Zapata et al., 2017; Almendros et al., 2014; Li et al., 2016; Miao et al., 2014).”
BackgroundThe role of PD-L1 in the immune dysfunction that mediates hypoxia-induced multiple organ injury
Sun, Y., Tan, J., Miao, Y., & Zhang, Q. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00742-x · Cited by 40
“PD-L1 has been shown to be overexpressed in the spleen and central nervous system (CNS) post-stroke in murine models [31]; similar changes in PD-L1 expression have been reported in monocytes from OSA patients [32, 33].”
BackgroundTorres, A., Motos, A., Cillóniz, C., Ceccato, A., Fernández‐Barat, L., Gabarrús, A., Bermejo-Martín, J. F., Ferrer, R., Riera, J., Pérez-Arnal, R., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06726-w · Cited by 39
Self-citationObstructive sleep apnea and cancer: a complex relationship
Marrone, O., & Bonsignore, M. R. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000729 · Cited by 38
“More recently, other mechanisms involved in immune regulation of cancer have been explored, including modulation of natural killer (NK) lymphocytes [57,58], regulatory T cells [59 & ], dendritic cells [60] and the PD-1–programmed cell death ligand (PD-L1) pathway [61].”
BackgroundPotential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer
Sánchez‐de‐la‐Torre, M., Cubillos‐Zapata, C., Veatch, O. J., Rio, F. G., Gozal, D., & Martínez‐García, M. Á. (2023) · Cancers · doi:10.3390/cancers15041061 · Cited by 42
“PD-1/PD-L1 [33,84] • Complex that participates in different cancer stages.”
BackgroundInfluentialSelf-citationRETRACTED: How microRNAs affect the PD-L1 and its synthetic pathway in cancer
Danbaran, G. R., Aslani, S., Sharafkandi, N., Hemmatzadeh, M., Hosseinzadeh, R., Azizi, G., Jadidi‐Niaragh, F., Babaie, F., & Mohammadi, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106594 · Cited by 36
RetractedLi, W., Chen, S., Lu, J., Mao, W., Zheng, S., Zhang, M., Wu, T., Chen, Y., Lu, K., Chu, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61560-0 · Cited by 39
“Given that HIF-1 α plays a fundamental role in the hypoxia signaling pathway 26,27 , we usedsiRNAtoinhibitYY1expressionandobserveditsimpactonHIF-1 α expressioninTHP-1cells.”
Shou, Y., Yang, L., Yang, Y., Zhu, X., Feng, L., & Xu, J. (2021) · Molecular Omics · doi:10.1039/d0mo00159g · Cited by 35
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Yue, B., Gao, Y., Hu, Y., Zhan, M., Wu, Y., & Lu, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1731 · Cited by 31
“40 The PD-1 pathway restricts glucose uptake, inhibits peroxisome proliferator-activated receptor-γ coactivator-1 α , suppresses glycolysis and OXPHOS and damages mitochondrial quality.”
BackgroundFang, Y., Hu, Y., Xu, F., & Feng, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374236 · Cited by 31
PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Cantero-Cid, R., Casas-Martín, J., Hernández-Jiménez, E., Cubillos‐Zapata, C., Varela-Serrano, A., Ortiz, J. A., Casarrubios, M., Montalbán-Hernández, K. M., Villacañas-Gil, I., Guerra, L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4853-0 · Cited by 31
“In addition, we have recently reported a similar behaviour in some other clinical contexts, such as sepsis [34] and obstructive sleep apnoea [35], leading to T-cell exhaustion and the progression of illness due to the inability of T-cells to work steadily.”
ResultSelf-citationSong, R., Baker, T. L., Watters, J. J., & Kumar, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031852 · Cited by 29
“However, 6 weeks of IH increased PD-L1 expression in splenocytes isolated from male mice, suggestive of an immunosuppressive phenotype, although circulating inflammatory markers were not evaluated [120].”
BackgroundJiang, F., Mao, Y., Lu, B., Zhou, G., & Wang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94128-1 · Cited by 31
Jamnani, A. N., Montazeri, M., Mirzakhani, M., Moosazadeh, M., & Haghighi, M. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01114-9 · Cited by 27
Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy
Liu, Z., Liu, X., Zhang, W., Gao, R., Wei, H., & Yu, C. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.010 · Cited by 27
The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer
Brzecka, A., Sarul, K., Dyła, T., Ávila-Rodriguez, M., Cabezas, R., Chubarev, V. N., Minyaeva, N. N., Klochkov, S. G., Неганова, М. Е., Михалева, Л. М., et al. (2020) · Current Genomics · doi:10.2174/1389202921999200403151720 · Cited by 30
Huang, M.-H., Zhang, X.-B., Wang, H.-L., Li, L.-X., Zeng, Y.-M., Wang, M., & Zeng, H.-Q. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.01.44 · Cited by 25
Liu, Y., Lu, M., Chen, J., Li, S., Deng, Y., Yang, S., Ou, Q., Li, J., Gao, P., Luo, Z., et al. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02369-1 · Cited by 26
Puech, B., Canivet, C. M., Teysseyre, L., Miltgen, G., Aujoulat, T., Caron, M., Combe, C., Jabot, J., Martinet, O., Allyn, J., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00950-1 · Cited by 23
Tan, N. K. W., Yap, D. W. T., Tan, B. K. J., Teo, Y. H., Tan, E. K. H., Chan, J. Y., Lee, H. Y., See, A., & Toh, S. T. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.10.027 · Cited by 22
Pasqueron, J., Dureau, P., Arcile, G., Duceau, B., Hariri, G., Lepère, V., Lebreton, G., Rouby, J., & Bouglé, A. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01013-9 · Cited by 22
Cubillos‐Zapata, C., Martínez‐García, M. Á., Díaz‐García, E., García-Tovar, S., Campos‐Rodríguez, F., Sánchez‐de‐la‐Torre, M., Nagore, E., Martorell, A., Blasco, L., Pastor, E., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00707-2022 · Cited by 21
Self-citationAbdelwahab, M., Marques, S., Huang, A., de Moraes, T. P., Previdelli, I. T. S., Cruz, J. A. W., Alsayed, A., & Capasso, R. (2023) · Otolaryngology · doi:10.1002/ohn.175 · Cited by 20
Cubillos‐Zapata, C., Martínez‐García, M. Á., Díaz‐García, E., Toledano, V., Campos‐Rodríguez, F., Sánchez‐de‐la‐Torre, M., Nagore, E., Martorell, A., Blasco, L., Pastor, E., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001247rr · Cited by 20
“Current smoker 32 (24) 20 (18) 10 (14) 7 (14)”
Self-citationSheng, Q., Tian, W., Dou, X., Zhang, C., Li, Y., Han, C. Q., Fan, Y., Lai, P., & Ding, Y. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i11.1255 · Cited by 20
Huette, P., Beyls, C., Mallat, J., Martineau, L., Besserve, P., Haye, G., Guilbart, M., Dupont, H., Guinot, P., Diouf, M., et al. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01881-4 · Cited by 20
Hypoxia-related gene signature for predicting LUAD patients’ prognosis and immune microenvironment
Chen, J., Fu, Y., Hu, J., & He, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155820 · Cited by 22
Dong, N., & Yue, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1654450 · Cited by 22
Mediano, O., Pumarega, I. C., Sánchez‐de‐la‐Torre, M., Alonso-Álvarez, M. L., Troncoso, M. F., Rio, F. G., Egea, C., Durán‐Cantolla, J., Téran‐Santos, J., Barbé, F., et al. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.05.017 · Cited by 19
Sun, X., Zhou, Z., Zhang, Y., Wang, J., Zhao, X., Jin, L., Zhai, T., Liu, X., Zhang, J., Mei, W., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01954-4 · Cited by 18
“Intermittent hypoxia suppresses autologous T-cell proliferation as well as the cytotoxic activity of CD8+ T-cells [14].”
BackgroundIntermittent Hypoxia Mediates Paraspeckle Protein-1 Upregulation in Sleep Apnea
Díaz‐García, E., García-Tovar, S., Casitas, R., Oriol, A. J., Zamarrón, E., Sánchez-Sánchez, B., Sastre-Perona, A., López‐Collazo, E., Rio, F. G., & Cubillos‐Zapata, C. (2021) · Cancers · doi:10.3390/cancers13153888 · Cited by 19
“In this situation, together with the IH-induced, HIF1α dependent, overexpression of the programmed death-1/programmed death-ligand 1 immune checkpoint [5], the limited ability to block cells that arise with neoplastic transformation could explain the higher incidence of tumors.”
BackgroundSelf-citationPSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea
Díaz‐García, E., García‐Sánchez, A., Alfaro, E., López-Fernández, C., Mañas, E., Pumarega, I. C., López‐Collazo, E., Rio, F. G., & Cubillos‐Zapata, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277551 · Cited by 16
Self-citationThe role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Salminen, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02504-x · Cited by 17
Cubillos‐Zapata, C., Troncoso, M. F., Díaz‐García, E., Alfaro, E., Rivera, C. M. G., Warnisher, M. T. P., Peces‐Barba, G., Seijo, L. M., & Rio, F. G. (2024) · ERJ Open Research · doi:10.1183/23120541.00777-2023 · Cited by 16
“In our patients with lung cancer, soluble PD-1 is related to OSA severity, in agreement with a previous report that PD-1 protein expression on CD8 T-cells from OSA patients is associated with hypoxaemia [16].”
BackgroundResultSelf-citationOu, X., & Lv, W. (2020) · Future Oncology · doi:10.2217/fon-2019-0692 · Cited by 15
Zhou, E., Zhou, T., Wang, X., Zhang, J., Guan, J., Yin, S., Huang, W., Yi, H., & Zou, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-93915-4 · Cited by 14
“Additionally, IH in OSA upregulates the programed cell death 1 (PDCD1) ligand/receptor crosstalk and reduces CD8 + T-cell activation and cytotoxicity, thus increasing tumor incidence and aggressiveness and the risk of infections in these patients 49 .”
Sleep‐disordered breathing and risk of the breast cancer: A meta‐analysis of cohort studies
Wei, L., Han, N., Sun, S., Ma, X., & Zhang, Y. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14793 · Cited by 14
Díaz‐García, E., Oriol, A. J., Casitas, R., García-Tovar, S., Sánchez-Sánchez, B., Zamarrón, E., López‐Collazo, E., Rio, F. G., & Cubillos‐Zapata, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082378 · Cited by 15
“Additionally, intermittent hypoxia (IH) triggers the hypoxia inducible factor (HIF1α) in OSA patients, in in vitro and in animal models [6,21,22].”
BackgroundSelf-citationOnishi, H., Nakamura, K., Yanai, K., Nagai, S., Nakayama, K., Oyama, Y., Fujimura, A., Ozono, K., & Yamasaki, A. (2022) · Oncology Reports · doi:10.3892/or.2022.8304 · Cited by 14
Infectious Risk and Variability of Hemoglobin Level in Patients Undergoing Hemodialysis
Nishi, H., Wang, J., Onishi, Y., & Nangaku, M. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.06.004 · Cited by 11
“In patients with obstructive sleep apnea, immune responses are altered by increases in inflammatory cytokines, decreases in the phagocytic capacity of neutrophils,(29) or stimulation of programmed death-ligand 1 (PD-L1)/PD-1 crosstalk.(30) Patients with sickle-cell disease display autonomic nerve dysfunction that may…”
BackgroundZhang, Q., Zhang, Q., Li, X., Du, G., Feng, X., Ding, R., Chi, Y., & Liu, Y. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13538 · Cited by 12
“38 Therefore, a personalized clinical treatment plan should be made according to individual's situation to reduce the cancer mortality of patients with different metabolic states.”
BackgroundTriggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance
Mei, T., Ye, T., Huang, D., Xie, Y., Xue, Y., Zhou, D., Wang, W., & Chen, J. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01009-6 · Cited by 12
He, X., Ding, J., Cheng, X., & Xiong, M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s343216 · Cited by 14
“revealed that immune cells (including T cells and natural killer cells) were inhibited or in a nonfunctional state under a hypoxic microenvironment.(10,11) Hypoxia also caused immu-”
BackgroundHe, Y., Yang, Y., Huang, W., Yang, S., Xue, X., Zhu, K., Tan, H., Sun, T., & Yang, W. (2023) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2232011 · Cited by 13
“…significantly reduces DNA damage caused by ionizing radiation and the activity of immune effector cells, whereas it increases the infiltration of immunosuppressive cells and the secretion of immunosuppressive molecules (Cubillos-Zapata et al. 2017; Chambers and Matosevic 2019; Maimela et al. 2019).”
BackgroundEffects of Obstructive Sleep Apnea on Airway Immunity and Susceptibility to Respiratory Infections
Epstein, S., Jun, D., Deng, J. C., & Zeidler, M. R. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.02.002 · Cited by 13
Cubillos‐Zapata, C., Martínez‐García, M. Á., Díaz‐García, E., Oriol, A. J., Campos‐Rodríguez, F., Sánchez‐de‐la‐Torre, M., Nagore, E., Martorell, A., Blasco, L., Pastor, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72481-x · Cited by 14
Self-citationPolasky, C., Steffen, A., Loyal, K., Lange, C., Bruchhage, K., & Pries, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111375 · Cited by 12
“Additionally, a clear connection of oxidative stress and increased PD-L1 expression has been proven in several studies [10,11].”
BackgroundAraki, T., Yamazaki, Y., Goto, N., Takahashi, Y. K., Ikuyama, Y., & Kosaka, M. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01948-2 · Cited by 12
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
Bryant, A. J., Mehrad, B., Brusko, T. M., West, J. D., & Moldawer, L. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082277 · Cited by 11
Pries, R., Lange, C., Behn, N., Bruchhage, K., & Steffen, A. (2022) · Biomedicines · doi:10.3390/biomedicines10081925 · Cited by 9
A checkpoint on innate myeloid cells in pulmonary arterial hypertension
Bryant, A. J., Fu, C., Lu, Y., Brantly, M., Mehrad, B., Moldawer, L. L., Brusko, T. M., Brittain, E. L., West, J. D., Austin, E. D., et al. (2018) · Pulmonary Circulation · doi:10.1177/2045894018823528 · Cited by 9
“It is known that PD-1 is induced on CD8þ T cells by hypoxia.(8) Therefore, we looked for PD-1 expression on these T lymphocytes in our model, finding a significant elevation within the lung samples from the hypoxia-treated group versus the controls (Fig.”
BackgroundShahul, S., Chaya, S. K., M., S., Lokesh, K. S., Khan, S. A., Aladakatti, A. R., Kumar, V., Vasanthan, V., Siddaiah, J. B., & Mahesh, P. A. (2025) · Diagnostics · doi:10.3390/diagnostics15162091 · Cited by 10
Pries, R., Kosyna, F. K., Depping, R., Plötze‐Martin, K., Lange, C., Meyhöfer, S., Meyhöfer, S. M., Marquardt, J. U., Bruchhage, K., & Steffen, A. (2024) · Scientific Reports · doi:10.1038/s41598-023-49921-5 · Cited by 9
Díaz‐García, E., García‐Sánchez, A., Alfaro, E., López-Fernández, C., Mañas, E., Casitas, R., Vega, S., Pumarega, I. C., Rio, F. G., & Cubillos‐Zapata, C. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.02.013 · Cited by 7
Self-citationMediano, O., Pumarega, I. C., Sánchez‐de‐la‐Torre, M., Alonso-Álvarez, M. L., Troncoso, M. F., Rio, F. G., Egea, C., Durán‐Cantolla, J., Téran‐Santos, J., Barbèc, F., et al. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.05.020 · Cited by 10
A wrinkle in time: circadian biology in pulmonary vascular health and disease
Bryant, A. J., Ebrahimi, E., Nguyen, A., Wolff, C. A., Gumz, M. L., Liu, A. C., & Esser, K. A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2021 · Cited by 7
Farm‐dust mediated protection of childhood asthma: Mass cytometry reveals novel cellular regulation
Beerweiler, C., Salvermoser, M., Theodorou, J., Böck, A., Sattler, F., Kulig, P., Toševski, V., & Schaub, B. (2024) · Allergy · doi:10.1111/all.16347 · Cited by 6
Zhang, L., Liu, F., & Li, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1764594 · Cited by 8
Kim, H.-K., Kim, D., Kim, W., Kim, E., Jang, W. I., & Kim, M. (2022) · Radiation Research · doi:10.1667/rade-21-00231.1 · Cited by 5
Cancer immunosurveillance in respiratory diseases
Cubillos‐Zapata, C., Díaz‐García, E., & Rio, F. G. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018021 · Cited by 6
Self-citationLi, K., Zhuo, Y., He, Y., Lei, F., He, P., Lang, Q., He, D., Zuo, S., Chen, S., Yang, X., et al. (2023) · PeerJ · doi:10.7717/peerj.15009 · Cited by 5
“Studies revealed a series of changes from cytokines, chemokines, andmetabolic products to blood cell categories in OSA (Yokoe et al., 2003; Ryan, Taylor & McNicholas, 2005; Cubillos-Zapata et al., 2017), as an increase in CRP, IL-6, IL-10, TNF-a, NFkB, PD-1, cell-free DNA, and neutrophil/lymphocyte ratio (NLR) (Rha et…”
BackgroundImpact of Intermittent Hypoxia on Sepsis Outcomes in a Murine Model
Chou, K., Cheng, S., Huang, S., Perng, D., Chang, S.-C., Chen, Y.-M., Hsu, H., & Hung, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49381-w · Cited by 6
Li, Y., Huang, H., Jiang, M.-C., Yu, N., Ye, X., Huang, Z., & Chen, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.975279 · Cited by 5
“It has been documented that T cells exhibit immune dysfunction in anoxic microenvironment (Cubillos-Zapata et al., 2017).”
BackgroundCan CPAP protect from cancer incidence in obstructive sleep apnoea patients? No evidence yet
Gambino, F., & Bonsignore, M. R. (2022) · European Respiratory Journal · doi:10.1183/13993003.02742-2021 · Cited by 5
Jagodzinski, N., Leichtle, A., Depping, R., Plötze‐Martin, K., Hakim, S. G., Bruchhage, K., & Pries, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-97314-7 · Cited by 4
Small Extracellular Vesicles Harboring PD-L1 in Obstructive Sleep Apnea
Recoquillon, S., Ali, S., Justeau, G., Riou, J., Martínez, M. C., Andriantsitohaina, R., Gagnadoux, F., & Trzépizur, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063208 · Cited by 4
“Furthermore, in the Princeps publication on the OSA/PD-L1 association, a significant increase was observed solely in severe OSA patients [10].”
BackgroundInfluentialLin, L., Zhang, W., Chen, Y., Ren, W., Zhao, J., Ouyang, W., He, Z., Su, W., Yao, H., & Yu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14450 · Cited by 5
Alfaro, E., Díaz‐García, E., García-Tovar, S., Galera, R., Casitas, R., Martínez-Cerón, E., Torres-Vargas, M., Padilla, J. M., Fernández, C. L., Pérez-Moreno, P., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31223-7 · Cited by 3
“For instance, PD-L1 is a direct transcriptional target of HIF-1α, and both PD-1 and PD-L1 have been shown to increase in a hypoxia-dependent manner in chronic respiratory diseases 34–36 .”
Self-citationExosomes in obstructive sleep apnea-related diseases
Chen, Z., Shang, Y., Ou, Y., Gong, S., Xiang, X., Ji, X., Peng, Y., & Ouyang, R. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003784 · Cited by 4
“[90,91] However, Recoquillon et al [18] found that OSA did not alter PD-L1 expression on exosomes and had no effect on lymphocyte activation or cytotoxicity.”
Minovès, M., Pépin, J., & Godin‐Ribuot, D. (2019) · European Respiratory Journal · doi:10.1183/13993003.02444-2018 · Cited by 4
Sleep apnoea and cancer risk: Where are we now?
Justeau, G., & Gagnadoux, F. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100905 · Cited by 4
Single-cell landscape of mouse lungs exposed to intermittent hypoxia
Zheng, P., Wang, L., Zhu, X., Mao, Z., Zhang, F., Zi, G., Chen, L., Liu, H., Zhou, L., & Liu, W. (2025) · Respiratory Research · doi:10.1186/s12931-025-03370-y · Cited by 2
“Some studies have suggested that IH exposure suppresses the cytotoxic activity of CD8 + T cells [42], and in tumor environments, IH exposure can lead to a reduction in the number of CD8 + T cells that release cytolytic enzymes (e.g., granzyme B)[43].”
Díaz‐García, E., Alfaro, E., Pérez-Moreno, P., López-Fernández, C., García-Sánchez, A., Martínez‐García, M. Á., Mañas, E., Pumarega, I. C., Casitas, R., Campos‐Rodríguez, F., et al. (2025) · Pulmonology · doi:10.1080/25310429.2025.2590870 · Cited by 2
Self-citationContinuous and intermittent hypoxia in cancer
O’Donnell, C., King, A., & Ryan, S. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018221 · Cited by 2
Obstructive sleep apnea and cancer: epidemiology, pathophysiology, and clinical aspects
Castrogiovanni, A., Modica, D. M., Amata, M., & Bonsignore, M. R. (2024) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.23.02081-8 · Cited by 2
Zhu, Y., Chen, Q., Wang, M., Qian, H., Song, Q., & Liu, B. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1638819 · Cited by 2
Axt, P. N., Mohr, T., Steffen, A., Plötze‐Martin, K., Jagodzinski, N., Bohnet, S., Drömann, D., Bruchhage, K., Franzen, K. F., & Pries, R. (2025) · Toxics · doi:10.3390/toxics13060472 · Cited by 1
Metadata
- Authors
- Cubillos-Zapata, C., Avendaño-Ortiz, J., Hernandez-Jimenez, E., Toledano, V., Casas-Martin, J., Varela-Serrano, A., Torres, M., Almendros, I., Casitas, R., Fernández-Navarro, I., Garcia-Sanchez, A., Aguirre, L. A., Farre, R., López-Collazo, E., & García-Rio, F.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Hospital Universitario La Paz (ES)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2017-10
- Volume
- 50
- Issue
- 4
- Pages
- 1700833
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2766335796
- Cited by
- 116
- References
- 37
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 15 · 2023: 11 · 2022: 17 · 2021: 20 · 2020: 16 · 2019: 14 · 2018: 4
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigación Sanitaria (FIS)-Fondos FEDER (PI13/01512, PI14/00004, PI14/01234, PIE15/00065)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- obstructive sleep apnea, intermittent hypoxia, PD-L1, PD-1, immune checkpoint, T cell dysfunction, CD8+ T cell cytotoxicity, monocytes, myeloid-derived suppressor cells, RORC, hypoxia-inducible factor-1α, cancer risk, infection susceptibility, immune dysregulation
- MeSH terms
- Adult, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Monocytes, Signal Transduction, Up-Regulation, CD8-Positive T-Lymphocytes, Sleep Apnea, Obstructive, B7-H1 Antigen, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.